A new method for sensitive and accurate proteome quantification in neat plasma
摘要
Blood is the primary source of protein biomarkers because it is readily accessible and reflects both physiological and pathological changes. However, ion suppression by high-abundance plasma proteins has long limited the coverage of mass spectrometry (MS)-based proteomics. Recent advances in nanomaterial-based enrichment have expanded blood proteome coverage to more than 6000 proteins. Nevertheless, whether the quantities of the enriched proteins proportionally reflect their true levels in neat blood – and thereby faithfully represent disease-associated variation – remains debated. We therefore developed NCTPro (Nanomaterial-enhanced Cross-Channel Transfer strategy for neat blood Proteomics), which enables in-depth plasma proteome quantification without enrichment-induced perturbation of endogenous protein concentrations. Using non-isobaric mass tags, NCTPro combines a reference channel of enriched low-abundance plasma proteins with a neat plasma channel in a single data-independent acquisition mass spectrometry (DIA-MS) run. Deep proteome coverage in the reference channel is transferred to the neat plasma channel through MS1 feature matching and MS2-assisted elucidation. In this way, NCTPro identifies more than 3000 proteins in neat plasma using a 23-min elution gradient – at least a three-fold increase in coverage over recent reports at similar throughput. Spike-in experiments further demonstrate that NCTPro provides accurate fold-change quantification, high precision, and high linearity, making it well suited to a wide range of clinical plasma proteomics studies.
参考文献
1 Tebani, A. et al. Integration of molecular profiles in a longitudinal wellness profiling cohort. Nature Communications 11 (2020). https://doi.org/10.1038/s41467-020-18148-7
2 Dayon, L., Cominetti, O. & Affolter, M. Proteomics of human biological fluids for biomarker discoveries: technical advances and recent applications. Expert Review of Proteomics 19, 131–151 (2022). https://doi.org/10.1080/14789450.2022.2070477
3 Melani, R. D. et al. The Blood Proteoform Atlas: A reference map of proteoforms in human hematopoietic cells. Science 375, 411–418 (2022). https://doi.org/doi:10.1126/science.aaz5284
4 Eldjarn, G. H. et al. Large-scale plasma proteomics comparisons through genetics and disease associations. Nature 622, 348–358 (2023). https://doi.org/10.1038/s41586-023-06563-x
5 Hampel, H. et al. Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape. Neuron 111, 2781–2799 (2023). https://doi.org/10.1016/j.neuron.2023.05.017
6 Blume, J. E. et al. Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona. Nature Communications 11 (2020). https://doi.org/10.1038/s41467-020-17033-7
7 Ferdosi, S. et al. Engineered nanoparticles enable deep proteomics studies at scale by leveraging tunable nano–bio interactions. Proceedings of the National Academy of Sciences 119, e2106053119 (2022). https://doi.org/doi:10.1073/pnas.2106053119
8 Huang, T. et al. Protein Coronas on Functionalized Nanoparticles Enable Quantitative and Precise Large-Scale Deep Plasma Proteomics. bioRxiv (2023). https://doi.org/10.1101/2023.08.28.555225
9 Suhre, K., McCarthy, M. I. & Schwenk, J. M. Genetics meets proteomics: perspectives for large population-based studies. Nature Reviews Genetics 22, 19–37 (2020). https://doi.org/10.1038/s41576-020-0268-2
10 Hortin, G. L. & Sviridov, D. The dynamic range problem in the analysis of the plasma proteome. Journal of Proteomics 73, 629–636 (2010). https://doi.org/10.1016/j.jprot.2009.07.001
11 Anderson, N. L. & Anderson, N. G. The Human Plasma Proteome. Molecular & Cellular Proteomics 1, 845–867 (2002). https://doi.org/10.1074/mcp.R200007-MCP200
12 Tirumalai, R. S. et al. Characterization of the Low Molecular Weight Human Serum Proteome. Molecular & Cellular Proteomics 2, 1096–1103 (2003). https://doi.org/10.1074/mcp.M300031-MCP200
13 Bi, X. et al. Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19. Cell Reports 38 (2022). https://doi.org/10.1016/j.celrep.2021.110271
14 Lee, P. Y., Osman, J., Low, T. Y. & Jamal, R. Plasma/serum proteomics: depletion strategies for reducing high-abundance proteins for biomarker discovery. Bioanalysis 11, 1799–1812 (2019). https://doi.org/10.4155/bio-2019-0145
15 Viode, A. et al. A simple, time- and cost-effective, high-throughput depletion strategy for deep plasma proteomics. Science Advances 9, eadf9717 (2023). https://doi.org/doi:10.1126/sciadv.adf9717
16 Qian, L. et al. Proteomic landscape of epithelial ovarian cancer. Nature Communications 15, 6462 (2024). https://doi.org/10.1038/s41467-024-50786-z
17 Bellei, E. et al. High-abundance proteins depletion for serum proteomic analysis: concomitant removal of non-targeted proteins. Amino Acids 40, 145–156 (2010). https://doi.org/10.1007/s00726-010-0628-x
18 Tu, C. et al. Depletion of Abundant Plasma Proteins and Limitations of Plasma Proteomics. Journal of Proteome Research 9, 4982–4991 (2010). https://doi.org/10.1021/pr100646w
19 Bader, J. M., Albrecht, V. & Mann, M. MS-Based Proteomics of Body Fluids: The End of the Beginning. Molecular & Cellular Proteomics 22 (2023). https://doi.org/10.1016/j.mcpro.2023.100577
20 Ashkarran, A. A. et al. Measurements of heterogeneity in proteomics analysis of the nanoparticle protein corona across core facilities. Nature Communications 13 (2022). https://doi.org/10.1038/s41467-022-34438-8
21 Wang, X. & Zhang, W. The Janus of Protein Corona on nanoparticles for tumor targeting, immunotherapy and diagnosis. Journal of Controlled Release 345, 832–850 (2022). https://doi.org/10.1016/j.jconrel.2022.03.056
22 Monopoli, M. P., Åberg, C., Salvati, A. & Dawson, K. A. Biomolecular coronas provide the biological identity of nanosized materials. Nature Nanotechnology 7, 779–786 (2012). https://doi.org/10.1038/nnano.2012.207
23 Korff, K. et al. Pre-Analytical Drivers of Bias in Bead-Enriched Plasma Proteomics. bioRxiv, 2025.2005.2007.652495 (2025). https://doi.org/10.1101/2025.05.07.652495
24 Gao, H. et al. Systematic evaluation of blood contamination in nanoparticle-based plasma proteomics. EMBO Mol Med 18, 275–296 (2026). https://doi.org/10.1038/s44321-025-00346-9
25 Thielert, M. et al. Robust dimethyl‐based multiplex‐DIA doubles single‐cell proteome depth via a reference channel. Molecular Systems Biology 19 (2023). https://doi.org/10.15252/msb.202211503
26 Derks, J. et al. Increasing the throughput of sensitive proteomics by plexDIA. Nature Biotechnology 41, 50–59 (2022). https://doi.org/10.1038/s41587-022-01389-w
27 Fu, Q. et al. A Proteomics Pipeline for Generating Clinical Grade Biomarker Candidates from Data-Independent Acquisition Mass Spectrometry (DIA-MS) Discovery. Angew Chem Int Ed Engl 63, e202409446 (2024). https://doi.org/10.1002/anie.202409446
28 Liu, Y. et al. Synthesis of Surface-Functionalized Molybdenum Disulfide Nanomaterials for Efficient Adsorption and Deep Profiling of the Human Plasma Proteome by Data-Independent Acquisition. Analytical Chemistry 94, 14956–14964 (2022). https://doi.org/10.1021/acs.analchem.2c02736
29 Wiśniewski, J. R., Zougman, A., Nagaraj, N. & Mann, M. Universal sample preparation method for proteome analysis. Nature Methods 6, 359–362 (2009). https://doi.org/10.1038/nmeth.1322
30 Boersema, P. J., Raijmakers, R., Lemeer, S., Mohammed, S. & Heck, A. J. R. Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics. Nature Protocols 4, 484–494 (2009). https://doi.org/10.1038/nprot.2009.21
31 Steger, M. et al. Time-resolved in vivo ubiquitinome profiling by DIA-MS reveals USP7 targets on a proteome-wide scale. Nat Commun 12, 5399 (2021). https://doi.org/10.1038/s41467-021-25454-1
32 Zeng, W.-F. et al. AlphaPeptDeep: a modular deep learning framework to predict peptide properties for proteomics. Nature Communications 13 (2022). https://doi.org/10.1038/s41467-022-34904-3
33 Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics 13, 2513–2526 (2014). https://doi.org/10.1074/mcp.M113.031591
34 Tyanova, S., Temu, T. & Cox, J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat Protoc 11, 2301–2319 (2016). https://doi.org/10.1038/nprot.2016.136
35 Liu, Y. et al. DeepRTAlign: toward accurate retention time alignment for large cohort mass spectrometry data analysis. Nat Commun 14, 8188 (2023). https://doi.org/10.1038/s41467-023-43909-5
36 Yu, F., Haynes, S. E. & Nesvizhskii, A. I. IonQuant Enables Accurate and Sensitive Label-Free Quantification With FDR-Controlled Match-Between-Runs. Mol Cell Proteomics 20, 100077 (2021). https://doi.org/10.1016/j.mcpro.2021.100077
37 Kalxdorf, M., Muller, T., Stegle, O. & Krijgsveld, J. IceR improves proteome coverage and data completeness in global and single-cell proteomics. Nat Commun 12, 4787 (2021). https://doi.org/10.1038/s41467-021-25077-6
38 Uhlen, M. et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science 366, eaax9198 (2019). https://doi.org/doi:10.1126/science.aax9198
39 Atlas, H. P. Protein detected in human plasma by mass spectrometry, <https://www.proteinatlas.org/humanproteome/blood/proteins+detected+in+ms> (2025).
40 Bhowmick, P., Roome, S., Borchers, C. H., Goodlett, D. R. & Mohammed, Y. An Update on MRMAssayDB: A Comprehensive Resource for Targeted Proteomics Assays in the Community. Journal of Proteome Research 20, 2105–2115 (2021). https://doi.org/10.1021/acs.jproteome.0c00961
41 Beimers, W. F. et al. Technical Evaluation of Plasma Proteomics Technologies. J Proteome Res 24, 3074–3087 (2025). https://doi.org/10.1021/acs.jproteome.5c00221
42 Uhlén, M. et al. Tissue-based map of the human proteome. Science 347, 1260419 (2015). https://doi.org/doi:10.1126/science.1260419
指标
DOI：
Submission ID：
下载次数
已发布
如何引用
下载引用
利益冲突声明
作者声明无任何需要披露的利益冲突。
Copyright
本预印本的版权持有者为作者/资助方。
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.